• ICPi-AKI, immune checkpoint inhibitor-associated AKI; AIN, acute interstitial nephritis; IQR, interquartile range; aOR, adjusted odds ratio.

  • 1.

    Robert C. A decade of immune-checkpoint inhibitors in cancer therapy. Nat Commun 2020; 11:3801. doi: 10.1038/s41467-020-17670-y

  • 2.

    Jacob JB, et al. Review of immune checkpoint inhibitors in immuno-oncology. Adv Pharmacol 2021; 91:111139. doi: 10.1016/bs.apha.2021.01.002

  • 3.

    Das S, Johnson DB. Immune-related adverse events and anti-tumor efficacy of immune checkpoint inhibitors. J Immunother Cancer 2019; 7:306. doi: 10.1186/s40425-019-0805-8

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 4.

    Gupta S, et al. Acute kidney injury in patients treated with immune checkpoint inhibitors. J Immunother Cancer 2021; 9:e003467. doi: 10.1136/jitc-2021-003467

New Data Highlight Acute Kidney Injury Associated with Immune Checkpoint Inhibitors

Mitchell H. Rosner Mitchell H. Rosner, MD, is the Henry B. Mulholland Professor of Medicine and Chair, Department of Medicine, Division of Nephrology, with University of Virginia Health, Charlottesville.

Search for other papers by Mitchell H. Rosner in
Current site
Google Scholar
PubMed
Close
Restricted access
Save